Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort

Fig. 3

Associations between estrogen plus progestin therapy (EPT) at baseline and risk of breast cancer by histology type among eligible postmenopausal women with intact uteri (n = 68,284) in the entire National Institutes of Health-AARP Diet and Health Study cohort (1996/1997–2011). BC, breast cancer. ER, estrogen receptor. PR, progesterone receptor

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us